Involvement of circadian clock gene Clock in diabetes-induced circadian augmentation of plasminogen activator inhibitor-1 (PAI-1) expression in the mouse heart

FEBS Letters

Volumn 579, Issue 17, 2005, Pages 3555-3559

  Oishi, Katsutaka ^a   Ohkura, Naoki ^b   Amagai, Noriko ^a   Ishida, Norio ^a,c  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Circadian rhythm; Clock; Diabetes; Mice; Plasminogen activator inhibitor 1; Streptozotocin

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTOR CLOCK;

ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; EVALUATION; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; WILD TYPE;

ANIMALS; CIRCADIAN RHYTHM; DIABETES MELLITUS, EXPERIMENTAL; MICE; MICE, MUTANT STRAINS; MYOCARDIUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; TRANS-ACTIVATORS;

EID: 21244448472     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.05.027     Document Type: Article

References (51)

1. K. Yamamoto, and H. Saito A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders Int. J. Hematol. 68 1998 371 385
2. F. Andreotti, and C. Kluft Circadian variation of fibrinolytic activity in blood Chronobiol. Int. 8 1991 336 351
3. K. Maemura, S.M. de la Monte, M.T. Chin, M.D. Layne, C.M. Hsieh, S.F. Yet, M.A. Perrella, and M.E. Lee CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression J. Biol. Chem. 275 2000 36847 36851
4. M.H. Vitaterna Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior Science 264 1994 719 725
5. K. Oishi, K. Miyazaki, and N. Ishida Functional CLOCK is not involved in the entrainment of peripheral clocks to the restricted feeding: entrainable expression of mPer2 and BMAL1 mRNAs in the heart of Clock mutant mice on Jcl:ICR background Biochem. Biophys. Res. Commun. 298 2002 198 202
6. S.M. Reppert, and D.R. Weaver Molecular analysis of mammalian circadian rhythms Annu. Rev. Physiol. 63 2001 647 676
7. S.M. Reppert, and D.R. Weaver Coordination of circadian timing in mammals Nature 418 2002 935 941
8. K. Oishi, H. Fukui, and N. Ishida Rhythmic expression of BMAL1 mRNA is altered in Clock mutant mice: differential regulation in the suprachiasmatic nucleus and peripheral tissues Biochem. Biophys. Res. Commun. 268 2000 164 171
9. J.A. Ripperger, L.P. Shearman, S.M. Reppert, and U. Schibler CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP Genes Dev. 14 2000 679 689
10. M.Y. Cheng, E.L. Bittman, S. Hattar, and Q.Y. Zhou Regulation of prokineticin 2 expression by light and the circadian clock BMC Neurosci. 6 2005 17
11. T. Matsuo, S. Yamaguchi, S. Mitsui, A. Emi, F. Shimoda, and H. Okamura Control mechanism of the circadian clock for timing of cell division in vivo Science 302 2003 255 259
12. K. Oishi Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes J. Biol. Chem. 278 2003 41519 41527
13. K. Oishi, H. Shirai, and N. Ishida CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor alpha (PPARalpha) in mice Biochem. J. 386 2005 575 581
14. G. Triqueneaux, S. Thenot, T. Kakizawa, M.P. Antoch, R. Safi, J.S. Takahashi, F. Delaunay, and V. Laudet The orphan receptor Rev-erbalpha gene is a target of the circadian clock pacemaker J. Mol. Endocrinol. 33 2004 585 608
15. D. Aronson Impaired modulation of circadian rhythms in patients with diabetes mellitus: a risk factor for cardiac thrombotic events? Chronobiol. Int. 18 2001 109 121
16. S.M. Haffner Insulin resistance, inflammation, and the prediabetic state Am. J. Cardiol. 92 2003 18J 26J
17. J.P. Tsikouris, J.A. Suarez, and G.E. Meyerrose Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agents J. Clin. Pharmacol. 42 2002 1187 1199
18. K. Oishi, N. Ohkura, M. Kasamatsu, N. Fukushima, H. Shirai, J. Matsuda, S. Horie, and N. Ishida Tissue-specific augmentation of circadian PAI-1 expression in mice with streptozotocin-induced diabetes Thromb. Res. 114 2004 129 135
19. W. Gai, P. Schott-Ohly, S. Schulte im Walde, and H. Gleichmann Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro Exp. Clin. Endocrinol. Diabetes 112 2004 29 37
20. H. Yang, and J.R. Wright Jr. Human beta cells are exceedingly resistant to streptozotocin in vivo Endocrinology 143 2002 2491 2495
21. K. Oishi, M. Kasamatsu, and N. Ishida Gene- and tissue-specific alterations of circadian clock gene expression in streptozotocin-induced diabetic mice under restricted feeding Biochem. Biophys. Res. Commun. 317 2004 330 334
22. P. Vague, and I. Juhan-Vague Fibrinogen, fibrinolysis and diabetes mellitus: a comment Diabetologia 40 1997 738 740
23. J.B. McGill, D.J. Schneider, C.L. Arfken, C.L. Lucore, and B.E. Sobel Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients Diabetes 43 1994 104 109
24. G. Gruden, P. Cavallo-Perin, M. Bazzan, S. Stella, A. Vuolo, and G. Pagano PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria Diabetes 43 1994 426 429
25. L.J. Garcia Frade, H. de la Calle, M.C. Torrado, J.I. Lara, L. Cuellar, and A. Garcia Avello Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitus Thromb. Res. 59 1990 51 59
26. F. Carmassi, M. Morale, R. Puccetti, F. De Negri, F. Monzani, R. Navalesi, and G. Mariani Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus Thromb. Res. 67 1992 643 654
27. D. Aronson, L.A. Weinrauch, J.A. D'Elia, G.H. Tofler, and A.J. Burger Circadian patterns of heart rate variability, fibrinolytic activity, and hemostatic factors in type I diabetes mellitus with cardiac autonomic neuropathy Am. J. Cardiol. 84 1999 449 453
28. J. Auwerx, R. Bouillon, D. Collen, and J. Geboers Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus Arteriosclerosis 8 1988 68 72
29. J. Skrha, A. Hodinar, J. Kvasnicka, and J. Hilgertova Relationship of oxidative stress and fibrinolysis in diabetes mellitus Diabetes Med. 13 1996 800 805
30. C. Hernandez, P. Chacon, L. Garcia-Pascual, J. Mesa, and R. Simo Relationship between lipoprotein(a) phenotypes and plaminogen activator inhibitor type 1 in diabetic patients Thromb. Res. 99 2000 119 127
31. M.E. Young, C.R. Wilson, P. Razeghi, P.H. Guthrie, and H. Taegtmeyer Alterations of the circadian clock in the heart by streptozotocin-induced diabetes J. Mol. Cell Cardiol. 34 2002 223 231
32. Y. Minami, K. Horikawa, M. Akiyama, and S. Shibata Restricted feeding induces daily expression of clock genes and Pai-1 mRNA in the heart of Clock mutant mice FEBS Lett. 526 2002 115 118
33. J.A. Schoenhard, L.H. Smith, C.A. Painter, M. Eren, C.H. Johnson, and D.E. Vaughan Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2 J. Mol. Cell Cardiol. 35 2003 473 481
34. P.G. Fattal, D.J. Schneider, B.E. Sobel, and J.J. Billadello Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1 J. Biol. Chem. 267 1992 12412 12415
35. D.J. Schneider, T.K. Nordt, and B.E. Sobel Stimulation by proinsulin of expression of plasminogen activator inhibitor type-I in endothelial cells Diabetes 41 1992 890 895
36. T.K. Nordt, H. Sawa, S. Fujii, C. Bode, and B.E. Sobel Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo J. Mol. Cell Cardiol. 30 1998 1535 1543
37. M. Suzuki, K. Akimoto, and Y. Hattori Glucose upregulates plasminogen activator inhibitor-1 gene expression in vascular smooth muscle cells Life Sci. 72 2002 59 66
38. Y. Chen, J.J. Billadello, and D.J. Schneider Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene Arterioscler. Thromb. Vasc. Biol. 20 2000 2696 2701
39. N. Shanmugam, M.A. Reddy, M. Guha, and R. Natarajan High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells Diabetes 52 2003 1256 1264
40. C.J. Bruzdzinski, M.R. Johnson, C.A. Goble, S.S. Winograd, and T.D. Gelehrter Mechanism of glucocorticoid induction of the rat plasminogen activator inhibitor-1 gene in HTC rat hepatoma cells: identification of cis-acting regulatory elements Mol. Endocrinol. 7 1993 1169 1177
41. S. Dennler, S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J.M. Gauthier Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene EMBO J. 17 1998 3091 3100
42. M.S. Sawdey, and D.J. Loskutoff Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta J. Clin. Invest. 88 1991 1346 1353
43. K. Macfelda Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes J. Mol. Cell Cardiol. 34 2002 1681 1691
44. P.A. Andreasen, B. Georg, L.R. Lund, A. Riccio, and S.N. Stacey Plasminogen activator inhibitors: hormonally regulated serpins Mol. Cell. Endocrinol. 68 1990 1 19
45. M. Mayer Biochemical and biological aspects of the plasminogen activation system Clin. Biochem. 23 1990 197 211
46. K. Takeshita Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction Am. J. Pathol. 164 2004 449 456
47. B. Venugopal, R. Sharon, R. Abramovitz, A. Khasin, and R. Miskin Plasminogen activator inhibitor-1 in cardiovascular cells: rapid induction after injecting mice with kainate or adrenergic agents Cardiovasc. Res. 49 2001 476 483
48. K. Oishi, K. Sakamoto, T. Okada, T. Nagase, and N. Ishida Humoral signals mediate the circadian expression of rat period homologue (rPer2) mRNA in peripheral tissues Neurosci. Lett. 256 1998 117 119
49. M. Takata Daily expression of mRNAs for the mammalian Clock genes Per2 and clock in mouse suprachiasmatic nuclei and liver and human peripheral blood mononuclear cells Jpn. J. Pharmacol. 90 2002 263 269
50. S. Koyanagi, Y. Kuramoto, H. Nakagawa, H. Aramaki, S. Ohdo, S. Soeda, and H. Shimeno A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells Cancer Res. 63 2003 7277 7283
51. D.E. Vaughan, P.J. Declerck, E. Van Houtte, M. De Mol, and D. Collen Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in vivo Circ. Res. 67 1990 1281 1286